339 related articles for article (PubMed ID: 34505707)
1. Prescription opioid use in Australian women of reproductive age: Implications for unplanned pregnancies.
Varney B; Zoega H; Gillies MB; Brett J; Pearson SA; Havard A
Br J Clin Pharmacol; 2022 Mar; 88(3):1298-1320. PubMed ID: 34505707
[TBL] [Abstract][Full Text] [Related]
2. Prescription opioid dispensing in Australian children and adolescents: a national population-based study.
Bell J; Paget SP; Nielsen TC; Buckley NA; Collins J; Pearson SA; Nassar N
Lancet Child Adolesc Health; 2019 Dec; 3(12):881-888. PubMed ID: 31604614
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and incidence of prescription opioid analgesic use in Australia.
Lalic S; Ilomäki J; Bell JS; Korhonen MJ; Gisev N
Br J Clin Pharmacol; 2019 Jan; 85(1):202-215. PubMed ID: 30338545
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Persistence of Prescription Opioid Use Following Hospital Discharge After Childbirth: An Australian Population-Based Cohort Study.
Varney B; Zoega H; Gillies MB; Gisev N; Weston Shand A; Pearson SA; Havard A
Anesth Analg; 2024 May; 138(5):970-979. PubMed ID: 37319031
[TBL] [Abstract][Full Text] [Related]
5. Prescribed opioid analgesic use developments in three Nordic countries, 2006-2017.
Muller AE; Clausen T; Sjøgren P; Odsbu I; Skurtveit S
Scand J Pain; 2019 Apr; 19(2):345-353. PubMed ID: 30677000
[TBL] [Abstract][Full Text] [Related]
6. Anticipating the effects of restricting high-dose preparations of strong opioids in Australia: A population-based analysis to inform the current policy debate.
Zheng D; Narayan SW; Zoega H; Litchfield M; Buckley NA; Pearson SA; Schaffer AL
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):521-527. PubMed ID: 30790376
[TBL] [Abstract][Full Text] [Related]
7. Trends in opioid utilisation in Australia, 2006-2015: Insights from multiple metrics.
Karanges EA; Buckley NA; Brett J; Blanch B; Litchfield M; Degenhardt L; Pearson SA
Pharmacoepidemiol Drug Saf; 2018 May; 27(5):504-512. PubMed ID: 29280224
[TBL] [Abstract][Full Text] [Related]
8. Opioid trends in Finland: a register-based nationwide follow-up study.
Keto J; Heiskanen T; Hamunen K; Kalliomäki ML; Linna M
Sci Rep; 2022 May; 12(1):7261. PubMed ID: 35508479
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical opioids utilisation by dose, formulation, and socioeconomic status in Queensland, Australia: a population study over 22 years.
Adewumi AD; Maravilla JC; Alati R; Hollingworth SA; Hu X; Loveday B; Connor JP
Int J Clin Pharm; 2021 Apr; 43(2):328-339. PubMed ID: 32964404
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Opioids Prescribed for Patients at Risk for Opioid Misuse Before and After Publication of the Centers for Disease Control and Prevention's Opioid Prescribing Guidelines.
Scherrer JF; Tucker J; Salas J; Zhang Z; Grucza R
JAMA Netw Open; 2020 Dec; 3(12):e2027481. PubMed ID: 33263762
[TBL] [Abstract][Full Text] [Related]
11. Prescription opioid analgesics for pain management in Australia: 20 years of dispensing.
Islam MM; McRae IS; Mazumdar S; Taplin S; McKetin R
Intern Med J; 2016 Aug; 46(8):955-63. PubMed ID: 26602489
[TBL] [Abstract][Full Text] [Related]
12. Association of the 2016 US Centers for Disease Control and Prevention Opioid Prescribing Guideline With Changes in Opioid Dispensing After Surgery.
Sutherland TN; Wunsch H; Pinto R; Newcomb C; Brensinger C; Gaskins L; Bateman BT; Neuman MD
JAMA Netw Open; 2021 Jun; 4(6):e2111826. PubMed ID: 34115128
[TBL] [Abstract][Full Text] [Related]
13. Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims.
Karanges EA; Blanch B; Buckley NA; Pearson SA
Br J Clin Pharmacol; 2016 Jul; 82(1):255-67. PubMed ID: 26991673
[TBL] [Abstract][Full Text] [Related]
14. Prescription opioid dispensing in New South Wales, Australia: spatial and temporal variation.
Islam MM; McRae IS; Mazumdar S; Simpson P; Wollersheim D; Fatema K; Butler T
BMC Pharmacol Toxicol; 2018 Jun; 19(1):30. PubMed ID: 29914572
[TBL] [Abstract][Full Text] [Related]
15. Prescription opioid use after vaginal delivery and subsequent persistent opioid use and misuse.
Zhu Y; Huybrechts KF; Desai RJ; Franklin JM; Hernandez-Diaz S; Krumme A; Straub L; Neuman M; Wunsch H; Levin R; Mogun H; Bateman BT
Am J Obstet Gynecol MFM; 2021 Mar; 3(2):100304. PubMed ID: 33383232
[TBL] [Abstract][Full Text] [Related]
16. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
[TBL] [Abstract][Full Text] [Related]
17. Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016.
Wei YJ; Chen C; Schmidt SO; LoCiganic WH; Winterstein AG
Drug Alcohol Depend; 2019 Nov; 204():107600. PubMed ID: 31586806
[TBL] [Abstract][Full Text] [Related]
18. Trends in opioid prescribing in Australia: a systematic review.
Donovan PJ; Arroyo D; Pattullo C; Bell A
Aust Health Rev; 2020 Apr; 44(2):277-287. PubMed ID: 32241339
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the population-level effects of oxycodone restrictions on prescription opioid utilization in Ontario.
Rudoler D; Kurdyak P; Gomes T; Huang A; Jones W; Littleford S; Paracha N; Fischer B
Pharmacoepidemiol Drug Saf; 2022 Jul; 31(7):769-778. PubMed ID: 35470515
[TBL] [Abstract][Full Text] [Related]
20. Opioid analgesics prescribing trends 2010-2019 in Slovenia: National database study.
Cebron Lipovec N
Hum Psychopharmacol; 2024 Mar; 39(2):e2891. PubMed ID: 38214662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
